Metoprololtartraat Accord (Metoprolol Tartrate)

Metoprolol Tartrate selectively blocks β1‑adrenergic receptors in the heart, preventing catecholamines from stimulating these receptors. This inhibition lowers sinus node firing, slows atrioventricular conduction, and reduces myocardial contractility. The overall effect is a decrease in heart rate, stroke volume, cardiac output, and systemic blood pressure, which lessens the heart’s oxygen demand.

The exact dose of Metoprololtartraat Accord is determined by the prescribing clinician based on the indication, disease severity, patient age, renal function and any concurrent medications. Typically, therapy starts at a low dose and may be titrated upward during follow‑up visits. Patients should follow the prescriber’s instructions and never adjust the dose on their own.

Safety data for Metoprolol Tartrate in pregnancy and lactation are limited. The drug is generally prescribed only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and alternative therapies with their healthcare provider before initiating treatment.

To place an order, visit the product page on gnhindia.com, enter the required quantity and submit the inquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled requirements) and the necessary import documentation.

Metoprolol Tartrate is a cardio‑selective β1‑blocker, offering fewer respiratory side effects than non‑selective agents such as propranolol, making it preferable for patients with asthma or chronic obstructive lung disease. Its efficacy in lowering blood pressure and heart rate is comparable to other selective blockers like atenolol. Choice of agent depends on individual comorbidities, tolerability and physician preference.

Metoprololtartraat Accord should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or near heat sources. Do not use the medication after the expiry date printed on the label.

The medication is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed. Consistency in the time of day helps maintain stable blood levels; patients should follow the dosing schedule provided on the prescription label.

Serious adverse reactions, although uncommon, include marked bradycardia, heart block, severe hypotension, bronchospasm in patients with reactive airway disease, and worsening heart failure. Patients should seek immediate medical attention if they experience fainting, chest pain, severe shortness of breath, or a rapid change in heart rhythm. Regular monitoring by a healthcare professional helps mitigate these risks.

Metoprololtartraat Accord is contraindicated in individuals with known hypersensitivity to metoprolol or any excipients, those with severe sinus bradycardia, second‑ or third‑degree atrioventricular block without a pacemaker, cardiogenic shock, or overt decompensated heart failure. Caution is also advised for patients with uncontrolled asthma or severe peripheral vascular disease. Clinicians must evaluate each patient’s medical history before prescribing.